Article info
PDFCorrespondence response
Response to: ‘Efficacy and safety of tocilizumab in patients with refractory Takayasu arteritis’ by Lee and Song
- Correspondence to Dr Yoshikazu Nakaoka, Department of Vascular Physiology, National Cerebral and Cardiovascular Center Research Institute, Osaka 565-8565, Japan; ynakaoka{at}ncvc.go.jp
Citation
Response to: ‘Efficacy and safety of tocilizumab in patients with refractory Takayasu arteritis’ by Lee and Song
Publication history
- Received January 10, 2018
- Revised January 29, 2018
- Accepted January 30, 2018
- First published February 10, 2018.
Online issue publication
December 18, 2018
Article Versions
- Previous version (10 February 2018).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2019. All rights reserved. No commercial use is permitted unless otherwise expressly granted.